STAQ Pharma, Inc. is recalling 905 syringes of HYDROmorphone HCl PF (10 mg/50 mL) and Morphine Sulfate PF (25 mg/25 mL). A limited number of syringes containing hydromorphone were incorrectly labeled as morphine sulfate, which could lead to healthcare providers administering the wrong medication. These products were distributed to hospitals, pharmacies, and clinical facilities in Colorado, Ohio, and Texas.
The mix-up between these two potent opioids creates a severe risk of medication errors. If hydromorphone is administered to a patient expecting morphine, it could lead to an accidental overdose, respiratory depression, or other life-threatening complications.
Rx only
Rx only
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.